Intermedius Genicular Nerve in the Treatment of Patients With Chondromalacia Patella (NCT05096520) | Clinical Trial Compass
UnknownNot Applicable
Intermedius Genicular Nerve in the Treatment of Patients With Chondromalacia Patella
Turkey (Türkiye)46 participantsStarted 2021-05-15
Plain-language summary
Radiofrequency application is a treatment method that temporarily prevents the transmission of pain in the nerve where the application is made through the heat emitted by radio waves.Partial inhibition of the functions of the nerves carrying the joint pain sensation with this method is the basis of the treatment.The intermedius genicular nerve carries the sensation of subpatellar pain due to chondromalacia.In this study,investigators aim is to investigate the effect of radiofrequency neurotomy applied to the intermedius genicular nerve, which receives the sensation of the patella, on pain and knee function in patients with a diagnosis of chondromalacia patella who have anterior knee pain that does not resolve despite conservative treatment, under the guidance of ultrasonography.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male/female aged \>18 years
* Diagnosis of chondromalacia patella after physical examination and MR imaging
* Those whose symptoms persist for \>3 months
* Participating in the study voluntarily
Exclusion Criteria:
* Pregnant patients
* History of previous knee surgery
* To have received physical therapy from the knee area in the last 6 months
* Previous RF treatment or any therapeutic injection of the knee such as steroid, hyaluronic acid within 3 months
* Those with pain radiating from the waist or hip
* Patients with neuropathic pain
* History of tumor, infectious, psychiatric disease, bleeding diathesis
* History of knee trauma in the last 6 months
* Those with systemic diseases such as hepatitis, coagulopathy
* Patients with BMI \>40
* Finding a leg length difference
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Knee Pain Severity of pain was assessed using the standard 10 cm VAS with 0 meant "no pain" at one end, and 10 meant "unbearable pain" at the other end initial, 4th week 7th week 24th week pain change
Timeframe: Change from Baseline , 4th week 12th week
Trial details
NCT IDNCT05096520
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital